What are the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for evaluation of immunoglobulin A (IgA) neuropathy?

Updated: May 19, 2020
  • Author: Sohail Abdul Salim, MD, FASN, FACP; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print

In its clinical practice guidelines for glomerulonephritis, Kidney Disease: Improving Global Outcomes (KDIGO) recommends the following for patients with IgA nephropathy [30] :

  • All patients should be assessed by biopsy for secondary causes of IgA nephropathy
  • Risk of progressession should be evaluated by measurement of proteinuria, blood pressure, and estimated glomerular filtration rate (eGFR) at the time of diagnosis and during follow-up
  • Pathological findings can be used to assess prognosis

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!